Should I sell or hold Jyoti Structure bought at Rs 70 and GlaxoSmithKline Pharma at Rs 760?
Niraj Jyoti Structures (Rs 138.7): Despite the recent surge in price, the stock still has upside potential. A move to the Rs 175-180 range appears likely. Considering your entry price and positive outlook, it would be better to remain invested and participate in the expected run-up in price. Hold with a stop-loss at Rs 125. Those willing to take risk may take fresh exposures on a move above Rs 148, with a stop-loss at Rs 135. GlaxoSmithKline (Rs 748): The stock appears to have at least one more move on the upside. The share price could move to the Rs 800-810 range. Taking into account the relatively wide tick-spread, having a stop-loss may not prove to be effective. Sell at least a portion of the holding if the stock declines below the negative trigger level of Rs 710. Readers can send in their queries, on not more than two companies, to techtrail@thehindu.co.in Queries can also be sent by post to: Tech Trail, 859/860 Kasturi Buildings, Anna Salai, Chennnai 600 002 We would endeavour t
